| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.2 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |